Tetradecanoylphorbol acetate


Curated chemical-disease associations from CTD
Disease IDDisease nameReference
MESH:D000077195 Squamous Cell Carcinoma of Head and Neck PMID:25125259
MESH:D001932 Brain Neoplasms PMID:6732984
MESH:D002277 Carcinoma PMID:17060372
MESH:D002294 Carcinoma, Squamous Cell PMID:18922899; PMID:20852150; PMID:35364107
MESH:D002471 Cell Transformation, Neoplastic PMID:11808923; PMID:16647178; PMID:18245498; PMID:18353537; PMID:20172950; PMID:20584749; PMID:24782466; PMID:28108223; PMID:2982513; PMID:31181187; PMID:32135139; PMID:6732984; PMID:8777434; PMID:9067545; PMID:9703276
MESH:D003872 Dermatitis PMID:16557482
MESH:D004487 Edema PMID:11698051; PMID:15177302; PMID:16716910; PMID:18670081; PMID:19161993; PMID:20709134; PMID:22036979; PMID:22494059; PMID:22760862; PMID:22981962; PMID:23399806; PMID:27378624; PMID:29458014; PMID:7812673; PMID:8113982; PMID:8190018; PMID:8273558; PMID:9599246; PMID:9811170
MESH:D004890 Erythema PMID:29458014
MESH:D005119 Extravasation of Diagnostic and Therapeutic Materials PMID:29458014
MESH:D006332 Cardiomegaly PMID:23939492
MESH:D006528 Carcinoma, Hepatocellular PMID:15138027; PMID:19447859
MESH:D006930 Hyperalgesia PMID:15626726
MESH:D006965 Hyperplasia PMID:19161993; PMID:1923905; PMID:20172950; PMID:20852150; PMID:22359662; PMID:22760862; PMID:22981962; PMID:23835587; PMID:24353828; PMID:29458014; PMID:35364107; PMID:3677084; PMID:7586191
MESH:D007249 Inflammation PMID:11698051; PMID:15177302; PMID:18262176; PMID:18670081; PMID:20172950; PMID:20423157; PMID:21235518; PMID:22036979; PMID:22494059; PMID:23835587; PMID:24304388; PMID:7562506; PMID:7812673; PMID:8273558
MESH:D008113 Liver Neoplasms PMID:14514661
MESH:D008175 Lung Neoplasms PMID:11807781; PMID:14514661
MESH:D008325 Mammary Neoplasms, Experimental PMID:8985016
MESH:D009361 Neoplasm Invasiveness PMID:15962302; PMID:19447859; PMID:20188714; PMID:22634262; PMID:22696189; PMID:23899529; PMID:24211270; PMID:24951586; PMID:25656647; PMID:25866363; PMID:26807887; PMID:28731287; PMID:30259628; PMID:9848099
MESH:D009362 Neoplasm Metastasis PMID:19447859; PMID:23288142
MESH:D009374 Neoplasms, Experimental PMID:20043298; PMID:20691676; PMID:25770929
MESH:D010146 Pain PMID:23562495; PMID:29655911
MESH:D010212 Papilloma PMID:11507057; PMID:12065085; PMID:17060372; PMID:18353537; PMID:18404319; PMID:18922899; PMID:20172950; PMID:20660715; PMID:20852150; PMID:22842666; PMID:23172667; PMID:2548529; PMID:26513295; PMID:3115617; PMID:35364107; PMID:7513819; PMID:8330346; PMID:9846968
MESH:D012868 Skin Abnormalities PMID:20172950
MESH:D012871 Skin Diseases PMID:23399806
MESH:D012878 Skin Neoplasms PMID:10381133; PMID:11241758; PMID:11243714; PMID:11507057; PMID:11807781; PMID:12065085; PMID:12504893; PMID:12543062; PMID:14997284; PMID:15063134; PMID:17060372; PMID:18404319; PMID:19161993; PMID:1923905; PMID:20043298; PMID:20045496; PMID:20454814; PMID:20660715; PMID:20691676; PMID:21159610; PMID:21533367; PMID:21597743; PMID:22359662; PMID:22760862; PMID:22842666; PMID:23835587; PMID:24353828; PMID:25770929; PMID:26100520; PMID:26513295; PMID:3098411; PMID:32662567; PMID:35364107; PMID:38299738; PMID:7586191; PMID:7871547; PMID:8330346; PMID:8597533; PMID:8985016; PMID:9714339; PMID:9766437
MESH:D017254 Leukemic Infiltration PMID:22981962
MESH:D017453 Dermatitis, Irritant PMID:11851881; PMID:21319177; PMID:25818598
MESH:D048629 Micronuclei, Chromosome-Defective PMID:9057100
MESH:D055371 Acute Lung Injury PMID:17071120
MESH:D063646 Carcinogenesis PMID:35364107

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.